Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study-Reference-Cited by-同舟云学术

Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study

Published:2005-03 Issue:3 Volume:96 Page:818-823
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fakiris Achilles J.,Moore David H.,Reddy Shailaja R.,Look Katherine Y.,Yiannoutsos Constantin T.,Randall Marcus E.,Cardenes Higinia R.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference39 articles.

1. SEER Cancer Statistics Review, 1975–2000,2004

2. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma;Hendrickson;American Journal of Surgical Pathology,1982

3. The outcome of stage I–II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma;Cirisanov;Gynecol. Oncol.,2000

4. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma;Sood;Int. J. Radiat. Oncol. Biol. Phys.,2003

5. Noninvasive papillary serous carcinoma of the endometrium;Gehrig;Obstetrics and Gynecology,2001

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant therapy of uterine clear cell carcinoma: a review;Archives of Gynecology and Obstetrics;2015-12-01

2. Intraperitoneal Radioactive Chromic Phosphate is a Well-Tolerated Adjuvant Treatment in Patients with Endometrial Cancer;Journal of Gynecologic Surgery;2015-04

3. Bioevaluation study of 32P-CP-PLLA particle brachytherapy in a rabbit VX2 lung tumor model;Applied Radiation and Isotopes;2012-04

4. Prognostic Determinants in Patients With Stage I Uterine Papillary Serous Carcinoma: A 15-Year Multi-Institutional Review;International Journal of Gynecologic Cancer;2012-03

5. CON: Not All Patients With Endometrial Cancer With Extrauterine Disease Should Receive Chemotherapy After Any Indicated Surgery;Clinical Ovarian Cancer;2011-12